CliffBio
small molecule

AMBIEN

ZOLPIDEM TARTRATE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMBIEN
Active ingredientZOLPIDEM TARTRATE
Strength10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1992
Marketing statusRX

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.